Tag:
NCPharma
Latest Headlines
Latest Headlines
Report: UK's Chris Evans shops $750M R&D startup plan
Sir Christopher Evans , one of the U.K.'s most high-profile biotech investors, is reportedly shopping for a plan to set up a new drug R&D company with $750 million that will be used to in-license
